A Pregnant Covid-19 Patient with Concomitant Infective Endocarditis: Case Report

Yıl 2022, , 197 - 201, 30.04.2022

Nurten Nur Aydın , Sibel İba Yılmaz , Murat Aydın

https://doi.org/10.24938/kutfd.1063560

Öz

The COVID-19 pandemic still continues to be a serious public health problem. There are concerns about the effects of this epidemic on pregnant women and the fetus due to the immunosuppressive state of pregnancy. The management of pregnant COVID-19 patients should be like non-pregnant patients; however, complications such as miscarriage, premature birth, and preeclampsia may increase. Pregnant COVID-19 patients may present with nonspecific symptoms and findings similar to other infectious diseases such as infective endocarditis. For this reason, it is important to investigate other accompanying infectious diseases and to make the diagnosis without delay in order to prevent possible complications. Our case is a pregnant patient who was admitted to the emergency department with the complaints of fever, weakness, cough and diagnosed with COVID-19 and infective endocarditis, and herein the diagnosis, management and outcome have been discussed.

Anahtar Kelimeler

Pregnant, infective endocarditis, COVID-19

COVID-19 İLE EŞ ZAMANLI ENFEKTİF ENDOKARDİT OLAN BİR GEBE HASTA: OLGU SUNUMU

Öz

COVID-19 pandemisi halen ciddi bir halk sağlığı problemi olarak etkisini sürdürmektedir. Bu salgının gebeliğin immunsupresif durumu nedeni ile gebelerde ve fetüs üzerindeki etkileri hakkında endişeler bulunmaktadır. Gebe COVID-19 hastalarının yönetimi gebe olmayan hastalar gibi yapılmalıdır; ancak düşük, erken doğum, preeklampsi gibi komplikasyonlarda artış görülebilmektedir. Gebe COVID-19 hastaları enfektif endokardit gibi diğer enfeksiyon hastalıkları ile benzer nonspesifik semptom ve bulgularla başvurabilmektedir. Bu nedenle eşlik edebilecek diğer enfeksiyon hastalıklarının araştırılması, tanısının gecikmeden konulması olabilecek komplikasyonları engelleme açısından önemlidir. Olgumuz ateş, halsizlik, öksürük yakınması ile acil servise başvuran COVID-19 ile enfektif endokardit tanısı konan gebe bir hasta olup teşhisi, yönetimi ve sonucu bildirilmiştir.

Anahtar Kelimeler

Gebe, enfektif endokardit, COVID-19

Kaynakça

• 1. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. American Journal of Obstetrics and Gynecology. 2020;222(5):415-26.
• 2. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study. Archives of Internal Medicine. 2009;169(5):463-73.
• 3. Wastnedge EA, Reynolds RM, Van Boeckel SR, Stock SJ, Denison FC, Maybin JA et al. Pregnancy and COVID-19. Physiological Reviews. 2021;101(1):303-18.
• 4. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320.
• 5. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648-55.
• 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-62.
• 7. Dias CN, Farias LABG, Cavalcante FJMB. Septic embolism in a patient with infective endocarditis and COVID-19. The American Journal of Tropical Medicine and Hygiene. 2020;103(6):2160.
• 8. Burwick RM, Yawetz S, Stephenson KE, Collier A-RY, Sen P, Blackburn BG et al. Compassionate use of remdesivir in pregnant women with severe coronavirus disease 2019. Clinical Infectious Diseases. 2021;73(11):e3996-e4004.
• 9. Kogler W, Omar M, Zoltowska D, Sattiraju S. Staphylococcus aureus infective endocarditis: role of transoesophageal echocardiography. BMJ Case Reports. 2020;13(9):e236530.
• 10. Spinoni EG, Degiovanni A, Della Corte F, Patti G. Infective endocarditis complicating COVID-19 pneumonia: a case report. European Heart Journal: Case Reports. 2020;4(6):1-5.
• 11. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal. 2015;36(44):3075-128.
• 12. Kaatz GW, Seo SM, Reddy VN, Bailey EM, Rybak MJ. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy. 1990;34(11):2081-5.
• 13. Gilbert D, Wood C, Kimbrough R. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon. Antimicrobial Agents and Chemotherapy. 1991;35(1):79-87.
• 14. Murray R. Staphylococcus aureus infective endocarditis: diagnosis and management guidelines. Internal Medicine Journal. 2005;35:S25-S44.
• 15. Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thrombosis Research. 2020;192:152-60.
• 16. Vanassche T, Peetermans WE, Herregods M-C, Herijgers P, Verhamme P. Anti-thrombotic therapy in infective endocarditis. Expert Review of Cardiovascular Therapy. 2011;9(9):1203-19.
• 17. Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S et al. A systematic scoping review of COVID‐19 during pregnancy and childbirth. International Journal of Gynecology & Obstetrics. 2020;150(1):47-52.
• 18. Cosma S, Carosso AR, Cusato J, Borella F, Carosso M, Bovetti M et al. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. American Journal of Obstetrics and Gynecology. 2021;224(4): 391.e1-391.e7.
• 19. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation. 1997;96(1):358-66.
• 20. Kebed KY, Bishu K, Al Adham RI, Baddour LM, Connolly HM, Sohail MR et al., eds. Pregnancy and postpartum infective endocarditis: a systematic review. Rochester. Elsevier, Mayo Clinic Proceedings, 2014.